Innovation at Nueve Healthcare
Innovation at Nueve Healthcare is about mastering complexity. We invest heavily in R&D to develop non-infringing, efficient, and scalable synthesis routes for the most challenging APIs, giving our partners a critical competitive edge.
R&D Capabilities
🔬 Process Chemistry
Our expertise in designing novel, cost-effective, and environmentally sustainable chemical processes.
🧪 Polymorphism & Crystallization
State-of-the-art labs for characterization and control of polymorphs, ensuring optimal API performance.
📊 Analytical Development
A full suite of advanced analytical techniques to ensure purity, stability, and compliance from development to commercial scale.
🔏 IP Strategy
Developing proprietary, non-infringing pathways to provide our partners with freedom to operate.
Technological Advancements
Manufacturing for the Future. We embrace Industry 4.0 principles, including the use of process analytical technology (PAT), continuous manufacturing, and green chemistry to enhance efficiency, reduce environmental impact, and ensure consistent quality.
Future Plans
Expanding Capacity
Increasing capacity in both existing plants over time and preparing five new provisioned plants with their supporting infrastructure.
New Technologies
Investing in continuous manufacturing by regularly upgrading equipment and technology.
Research Partnerships
Exploring partnerships with other institutions for innovative drug development alongside our in-house R&D facility.
Formulation Expansion
Venturing into the formulation industry alongside API and Intermediates manufacturing.
Production Projection (Next 3 Years)
| Year | API Production | Intermediates Production |
|---|---|---|
| 2026-27 | 1,60,000 kg | 70,000 kg |
| 2027-28 | 3,00,000 kg | 4,50,000 kg |
| 2028-29 | 4,50,000 kg | 8,00,000 kg |